FMR LLC's Schedule 13G Filing for Camp4 Therapeutics Corp

FMR LLC filed a Schedule 13G with the SEC, disclosing its ownership of 15% of the common stock of Camp4 Therapeutics Corp. The filing indicates that FMR LLC beneficially owns 3,023,434 shares, with sole voting power over 3,022,105 shares and sole dispositive power over all 3,023,434 shares. The filing also mentions that one or more other persons have the right to receive dividends or direct the sale of the shares, with Select Biotechnology Portfolio owning 1,463,592 shares, representing 7.3% of the total outstanding common stock as of September 30, 2025. The filing was signed by Stephanie J. Brown on behalf of FMR LLC and Abigail P. Johnson, both under power of attorney.